Stem Cell Therapy: Cutting Edge Medical Science Just Got Sharper.

Amazing, miraculous things are happening with stem cells. But where? Unfortunately, the big players in healthcare are making it as hard as possible for these revolutionary medicines to the general public. Whether curing decades long auto-immune conditions like MS or ulcerative colitis, reversing the damage from strokes and putting arthritis into remission, stem cells are doing it right now. That’s why Josh Ketner setup shop in Mexico, and is seeing patients from all over the world and changing their lives with just one stem cell session.

Josh Ketner is the founder and a leading expert at Dreambody Clinic, specialising in regenerative medicine and holistic health. With a passion for helping individuals achieve their full potential through natural healing methods, Josh focuses on advanced treatments that promote long-term wellness and vitality. Drawing from his deep knowledge in biomolecular medicine, he combines cutting-edge techniques with personalised care to address chronic conditions, pain management, and overall well-being. 

Join us as we explore:

• Everything stems cells and stem cell therapies – what are mesenchyme stem cells, why it is a misconception that they magically become any type of cell and the paracrine effect.
• Treating cognitive decline, strokes and brain injuries by injecting 2 ml of mesenchyme stem cells into the base of the spine (intrathecal)!
• The clinical success Josh sees with IV mesenchyme stem cells, including reversing biological age and putting autoimmune and gut disorders into remission with one IV bag!
• Why the notion that using your own stem cell is the best approach is not right. 
• The value of saving the umbilical cord and placenta for future use, but why it’s not actually for the stem cells.
• Why the stem cell injury is being stifled by Big Pharma by How to work with Josh and the Dreambody Clinic

Contact: 

• Website: https://dreambody.clinic

Mentions: 

• Person – Dr Arnold Caplan: https://onlinelibrary.wiley.com/doi/10.1002/jor.1100090504